nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.183	0.363	CbGbCtD
Tolcapone—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.183	0.363	CbGbCtD
Tolcapone—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.139	0.275	CbGbCtD
Tolcapone—COMT—Methylation—CYP1A2—chronic obstructive pulmonary disease	0.00721	0.122	CbGpPWpGaD
Tolcapone—Tolmetin—CXCL8—chronic obstructive pulmonary disease	0.00452	0.395	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00451	0.0761	CbGpPWpGaD
Tolcapone—Tolmetin—MPO—chronic obstructive pulmonary disease	0.00352	0.308	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00345	0.0583	CbGpPWpGaD
Tolcapone—Niclosamide—CYP1A2—chronic obstructive pulmonary disease	0.0034	0.297	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00327	0.0553	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00221	0.0374	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.00205	0.0347	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.00201	0.034	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00176	0.0297	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.00161	0.0272	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00152	0.0257	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00151	0.0254	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.00146	0.0247	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00127	0.0214	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.0012	0.0202	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00106	0.018	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00106	0.0178	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00102	0.0173	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000976	0.0165	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.00097	0.0164	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.000918	0.0155	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000891	0.015	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000881	0.0149	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000772	0.013	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000748	0.0126	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000743	0.0125	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00074	0.0125	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00073	0.0123	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000695	0.0117	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000618	0.0104	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000609	0.0103	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000568	0.00959	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00056	0.00945	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000538	0.00909	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000531	0.00896	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000511	0.00863	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000452	0.00763	CbGpPWpGaD
Tolcapone—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000448	0.00106	CcSEcCtD
Tolcapone—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00105	CcSEcCtD
Tolcapone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000444	0.00105	CcSEcCtD
Tolcapone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000444	0.00105	CcSEcCtD
Tolcapone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00105	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000441	0.00746	CbGpPWpGaD
Tolcapone—Infection—Formoterol—chronic obstructive pulmonary disease	0.000441	0.00104	CcSEcCtD
Tolcapone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000441	0.00104	CcSEcCtD
Tolcapone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00103	CcSEcCtD
Tolcapone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00103	CcSEcCtD
Tolcapone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00103	CcSEcCtD
Tolcapone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000437	0.00103	CcSEcCtD
Tolcapone—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000436	0.00103	CcSEcCtD
Tolcapone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00103	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000436	0.00736	CbGpPWpGaD
Tolcapone—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000436	0.00103	CcSEcCtD
Tolcapone—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000436	0.00103	CcSEcCtD
Tolcapone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000435	0.00102	CcSEcCtD
Tolcapone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000435	0.00102	CcSEcCtD
Tolcapone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00102	CcSEcCtD
Tolcapone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00102	CcSEcCtD
Tolcapone—COMT—Metabolism—APIP—chronic obstructive pulmonary disease	0.000433	0.00731	CbGpPWpGaD
Tolcapone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.00102	CcSEcCtD
Tolcapone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00102	CcSEcCtD
Tolcapone—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000431	0.00102	CcSEcCtD
Tolcapone—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000431	0.00102	CcSEcCtD
Tolcapone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00043	0.00101	CcSEcCtD
Tolcapone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00101	CcSEcCtD
Tolcapone—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00101	CcSEcCtD
Tolcapone—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000427	0.001	CcSEcCtD
Tolcapone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000426	0.001	CcSEcCtD
Tolcapone—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000423	0.000995	CcSEcCtD
Tolcapone—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000992	CcSEcCtD
Tolcapone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.000988	CcSEcCtD
Tolcapone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.000981	CcSEcCtD
Tolcapone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000415	0.000978	CcSEcCtD
Tolcapone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000415	0.000978	CcSEcCtD
Tolcapone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000413	0.000973	CcSEcCtD
Tolcapone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.000972	CcSEcCtD
Tolcapone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000412	0.000971	CcSEcCtD
Tolcapone—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.000969	CcSEcCtD
Tolcapone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000409	0.000964	CcSEcCtD
Tolcapone—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000409	0.000963	CcSEcCtD
Tolcapone—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000407	0.00096	CcSEcCtD
Tolcapone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000406	0.000955	CcSEcCtD
Tolcapone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000405	0.000955	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000405	0.000953	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.000953	CcSEcCtD
Tolcapone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.0004	0.000942	CcSEcCtD
Tolcapone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000399	0.000941	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000396	0.000934	CcSEcCtD
Tolcapone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000396	0.000933	CcSEcCtD
Tolcapone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000396	0.000933	CcSEcCtD
Tolcapone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000395	0.00093	CcSEcCtD
Tolcapone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000395	0.00093	CcSEcCtD
Tolcapone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000392	0.000923	CcSEcCtD
Tolcapone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000391	0.000921	CcSEcCtD
Tolcapone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000391	0.000921	CcSEcCtD
Tolcapone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000391	0.00092	CcSEcCtD
Tolcapone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000389	0.000917	CcSEcCtD
Tolcapone—Injury—Prednisone—chronic obstructive pulmonary disease	0.000387	0.000911	CcSEcCtD
Tolcapone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000387	0.000911	CcSEcCtD
Tolcapone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000386	0.000909	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000384	0.000903	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000384	0.000903	CcSEcCtD
Tolcapone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000383	0.000902	CcSEcCtD
Tolcapone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000383	0.000902	CcSEcCtD
Tolcapone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000383	0.000902	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000382	0.0009	CcSEcCtD
Tolcapone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.000895	CcSEcCtD
Tolcapone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00038	0.000895	CcSEcCtD
Tolcapone—Pain—Formoterol—chronic obstructive pulmonary disease	0.00038	0.000895	CcSEcCtD
Tolcapone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00038	0.000895	CcSEcCtD
Tolcapone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000379	0.000892	CcSEcCtD
Tolcapone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000377	0.000887	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000376	0.000885	CcSEcCtD
Tolcapone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000375	0.000883	CcSEcCtD
Tolcapone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000374	0.000881	CcSEcCtD
Tolcapone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000373	0.000878	CcSEcCtD
Tolcapone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000372	0.000876	CcSEcCtD
Tolcapone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000372	0.000876	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.00627	CbGpPWpGaD
Tolcapone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000371	0.000874	CcSEcCtD
Tolcapone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.000871	CcSEcCtD
Tolcapone—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.000871	CcSEcCtD
Tolcapone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000369	0.00087	CcSEcCtD
Tolcapone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.000867	CcSEcCtD
Tolcapone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000368	0.000866	CcSEcCtD
Tolcapone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000366	0.000862	CcSEcCtD
Tolcapone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000366	0.000862	CcSEcCtD
Tolcapone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000366	0.000861	CcSEcCtD
Tolcapone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.000859	CcSEcCtD
Tolcapone—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000364	0.000858	CcSEcCtD
Tolcapone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000364	0.000857	CcSEcCtD
Tolcapone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.000855	CcSEcCtD
Tolcapone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000363	0.000855	CcSEcCtD
Tolcapone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000855	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.000853	CcSEcCtD
Tolcapone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000362	0.000852	CcSEcCtD
Tolcapone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.000845	CcSEcCtD
Tolcapone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000359	0.000845	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000358	0.00604	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000356	0.000838	CcSEcCtD
Tolcapone—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000838	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000356	0.000838	CcSEcCtD
Tolcapone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000353	0.000831	CcSEcCtD
Tolcapone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000353	0.000831	CcSEcCtD
Tolcapone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.000827	CcSEcCtD
Tolcapone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000351	0.000827	CcSEcCtD
Tolcapone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.000827	CcSEcCtD
Tolcapone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000351	0.000827	CcSEcCtD
Tolcapone—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00035	0.000825	CcSEcCtD
Tolcapone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.000824	CcSEcCtD
Tolcapone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000347	0.000818	CcSEcCtD
Tolcapone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.000817	CcSEcCtD
Tolcapone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000347	0.000817	CcSEcCtD
Tolcapone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000347	0.000817	CcSEcCtD
Tolcapone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000346	0.000814	CcSEcCtD
Tolcapone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000346	0.000814	CcSEcCtD
Tolcapone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000345	0.000812	CcSEcCtD
Tolcapone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000345	0.000812	CcSEcCtD
Tolcapone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00081	CcSEcCtD
Tolcapone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000344	0.00081	CcSEcCtD
Tolcapone—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000809	CcSEcCtD
Tolcapone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000343	0.000808	CcSEcCtD
Tolcapone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00034	0.000802	CcSEcCtD
Tolcapone—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00034	0.0008	CcSEcCtD
Tolcapone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000339	0.000797	CcSEcCtD
Tolcapone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000338	0.000797	CcSEcCtD
Tolcapone—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000794	CcSEcCtD
Tolcapone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000333	0.000785	CcSEcCtD
Tolcapone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.000781	CcSEcCtD
Tolcapone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000332	0.000781	CcSEcCtD
Tolcapone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.000771	CcSEcCtD
Tolcapone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000327	0.000771	CcSEcCtD
Tolcapone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000327	0.00077	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000321	0.00542	CbGpPWpGaD
Tolcapone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000321	0.000755	CcSEcCtD
Tolcapone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000319	0.000751	CcSEcCtD
Tolcapone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.000751	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000317	0.00535	CbGpPWpGaD
Tolcapone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000314	0.00074	CcSEcCtD
Tolcapone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000314	0.00074	CcSEcCtD
Tolcapone—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000739	CcSEcCtD
Tolcapone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000312	0.000735	CcSEcCtD
Tolcapone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.000728	CcSEcCtD
Tolcapone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000308	0.000725	CcSEcCtD
Tolcapone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.000716	CcSEcCtD
Tolcapone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000304	0.000716	CcSEcCtD
Tolcapone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000303	0.000712	CcSEcCtD
Tolcapone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000301	0.000709	CcSEcCtD
Tolcapone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000299	0.000705	CcSEcCtD
Tolcapone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000701	CcSEcCtD
Tolcapone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000297	0.000699	CcSEcCtD
Tolcapone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000294	0.000692	CcSEcCtD
Tolcapone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000294	0.000692	CcSEcCtD
Tolcapone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000288	0.000678	CcSEcCtD
Tolcapone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000676	CcSEcCtD
Tolcapone—COMT—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000287	0.00484	CbGpPWpGaD
Tolcapone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000667	CcSEcCtD
Tolcapone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000282	0.000665	CcSEcCtD
Tolcapone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000282	0.000665	CcSEcCtD
Tolcapone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.00066	CcSEcCtD
Tolcapone—Rash—Formoterol—chronic obstructive pulmonary disease	0.00028	0.00066	CcSEcCtD
Tolcapone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00028	0.000659	CcSEcCtD
Tolcapone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00028	0.000659	CcSEcCtD
Tolcapone—COMT—Metabolism—GC—chronic obstructive pulmonary disease	0.000279	0.00471	CbGpPWpGaD
Tolcapone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.000655	CcSEcCtD
Tolcapone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000278	0.000655	CcSEcCtD
Tolcapone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000655	CcSEcCtD
Tolcapone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.000654	CcSEcCtD
Tolcapone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000277	0.000653	CcSEcCtD
Tolcapone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000277	0.000652	CcSEcCtD
Tolcapone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000274	0.000646	CcSEcCtD
Tolcapone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000274	0.000646	CcSEcCtD
Tolcapone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000274	0.000644	CcSEcCtD
Tolcapone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000273	0.000642	CcSEcCtD
Tolcapone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000636	CcSEcCtD
Tolcapone—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000633	CcSEcCtD
Tolcapone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000269	0.000633	CcSEcCtD
Tolcapone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.000628	CcSEcCtD
Tolcapone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.000626	CcSEcCtD
Tolcapone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.000624	CcSEcCtD
Tolcapone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000623	CcSEcCtD
Tolcapone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000264	0.000623	CcSEcCtD
Tolcapone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.000622	CcSEcCtD
Tolcapone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.000621	CcSEcCtD
Tolcapone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000264	0.000621	CcSEcCtD
Tolcapone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.000619	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00026	0.00439	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000259	0.00438	CbGpPWpGaD
Tolcapone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00061	CcSEcCtD
Tolcapone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000258	0.000609	CcSEcCtD
Tolcapone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.000599	CcSEcCtD
Tolcapone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00059	CcSEcCtD
Tolcapone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000249	0.000587	CcSEcCtD
Tolcapone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.000584	CcSEcCtD
Tolcapone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000582	CcSEcCtD
Tolcapone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00058	CcSEcCtD
Tolcapone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000245	0.000577	CcSEcCtD
Tolcapone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.000567	CcSEcCtD
Tolcapone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000557	CcSEcCtD
Tolcapone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.000553	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000233	0.000548	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000229	0.00386	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000226	0.00382	CbGpPWpGaD
Tolcapone—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000526	CcSEcCtD
Tolcapone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000518	CcSEcCtD
Tolcapone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000512	CcSEcCtD
Tolcapone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000216	0.000509	CcSEcCtD
Tolcapone—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000508	CcSEcCtD
Tolcapone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000206	0.000485	CcSEcCtD
Tolcapone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000475	CcSEcCtD
Tolcapone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000199	0.000468	CcSEcCtD
Tolcapone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000198	0.000467	CcSEcCtD
Tolcapone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000466	CcSEcCtD
Tolcapone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000464	CcSEcCtD
Tolcapone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000455	CcSEcCtD
Tolcapone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000453	CcSEcCtD
Tolcapone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000452	CcSEcCtD
Tolcapone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000191	0.00045	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00321	CbGpPWpGaD
Tolcapone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000443	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.00317	CbGpPWpGaD
Tolcapone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000436	CcSEcCtD
Tolcapone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000429	CcSEcCtD
Tolcapone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000429	CcSEcCtD
Tolcapone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000428	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000427	CcSEcCtD
Tolcapone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00018	0.000424	CcSEcCtD
Tolcapone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000177	0.000417	CcSEcCtD
Tolcapone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000412	CcSEcCtD
Tolcapone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000409	CcSEcCtD
Tolcapone—Shock—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000405	CcSEcCtD
Tolcapone—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000404	CcSEcCtD
Tolcapone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000402	CcSEcCtD
Tolcapone—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00017	0.0004	CcSEcCtD
Tolcapone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000398	CcSEcCtD
Tolcapone—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000167	0.000392	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000161	0.00272	CbGpPWpGaD
Tolcapone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000159	0.000375	CcSEcCtD
Tolcapone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000159	0.000375	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000159	0.00268	CbGpPWpGaD
Tolcapone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00037	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000156	0.00264	CbGpPWpGaD
Tolcapone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000362	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000152	0.00257	CbGpPWpGaD
Tolcapone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000358	CcSEcCtD
Tolcapone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000357	CcSEcCtD
Tolcapone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.000357	CcSEcCtD
Tolcapone—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000355	CcSEcCtD
Tolcapone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.000355	CcSEcCtD
Tolcapone—COMT—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000151	0.00254	CbGpPWpGaD
Tolcapone—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000352	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000146	0.00246	CbGpPWpGaD
Tolcapone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000144	0.000339	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000144	0.00243	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000337	CcSEcCtD
Tolcapone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000337	CcSEcCtD
Tolcapone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000327	CcSEcCtD
Tolcapone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000325	CcSEcCtD
Tolcapone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000325	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00233	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000137	0.00232	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.0023	CbGpPWpGaD
Tolcapone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000129	0.000303	CcSEcCtD
Tolcapone—COMT—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000127	0.00214	CbGpPWpGaD
Tolcapone—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.000295	CcSEcCtD
Tolcapone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000291	CcSEcCtD
Tolcapone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000282	CcSEcCtD
Tolcapone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000116	0.000272	CcSEcCtD
Tolcapone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000262	CcSEcCtD
Tolcapone—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000111	0.00188	CbGpPWpGaD
Tolcapone—Rash—Prednisone—chronic obstructive pulmonary disease	0.00011	0.00026	CcSEcCtD
Tolcapone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000259	CcSEcCtD
Tolcapone—Headache—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000258	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000106	0.00178	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000104	0.00176	CbGpPWpGaD
Tolcapone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000245	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.71e-05	0.00164	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.2e-05	0.00155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.92e-05	0.00134	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.36e-05	0.00124	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	7.3e-05	0.00123	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	7.16e-05	0.00121	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.66e-05	0.00112	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—chronic obstructive pulmonary disease	6.25e-05	0.00106	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NOS3—chronic obstructive pulmonary disease	5.98e-05	0.00101	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.3e-05	0.000896	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.91e-05	0.000661	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.87e-05	0.000653	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.61e-05	0.000609	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.53e-05	0.000596	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.25e-05	0.000549	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.71e-05	0.000458	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.67e-05	0.000452	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.49e-05	0.000421	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.36e-05	0.000399	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.61e-05	0.000271	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.54e-05	0.000259	CbGpPWpGaD
